Isracann Biosciences Inc.
ISCNF
$0.00
$0.000.00%
OTC PK
| 08/31/2022 | 05/31/2022 | 02/28/2022 | 11/30/2021 | 08/31/2021 | |
|---|---|---|---|---|---|
| Net Income | 88.59% | -340.32% | 29.89% | -84.86% | 97.87% |
| Total Depreciation and Amortization | -1.22% | 0.00% | -1.20% | -1.19% | -13.40% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.39% | 6,045.91% | 255.70% | 125.73% | -100.18% |
| Change in Net Operating Assets | -58.98% | 490.53% | -81.42% | 412.24% | 5.87% |
| Cash from Operations | 25.16% | 58.74% | 10.38% | -28.81% | 59.98% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 100.00% | 15.68% |
| Cash from Investing | -- | -- | -- | 100.00% | -6.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.71% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 15.07% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 92.25% | -1,009.09% | 91.30% | 1,250.00% | 80.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.84% | 81.26% | 10.87% | -1.38% | -55.36% |